Immix Biopharma, Inc. SEC filings IMMX
Immix Biopharma, Inc. has 244 filings in SEC EDGAR's recent list, going back to Jul 20, 2021. Its latest annual report, Form ARS, was filed on Apr 6, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 7, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Sep 30, 2026 (other events). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| EFFECT | Filing | Jan 22, 2026 | — |
| CORRESP | Letter to the SEC | Jan 16, 2026 | — |
| UPLOAD | Letter from the SEC | Jan 16, 2026 | — |
| EFFECT | Filing | Dec 1, 2025 | — |
| CORRESP | Letter to the SEC | Nov 26, 2025 | — |
| D | Filing | May 20, 2024 | — |
| EFFECT | Filing | Sep 28, 2023 | — |
| CORRESP | Letter to the SEC | Sep 26, 2023 | — |
| UPLOAD | Letter from the SEC | Sep 26, 2023 | — |
| EFFECT | Filing | Jan 11, 2023 | — |
| CORRESP | Letter to the SEC | Jan 9, 2023 | — |
| UPLOAD | Letter from the SEC | Jan 6, 2023 | — |
| RW | Filing | Jul 19, 2022 | — |
| RW WD | Filing | Jun 30, 2022 | — |
| DRS | Filing | May 24, 2022 | — |
| SEC STAFF LETTER | Filing | Dec 15, 2021 | — |
| EFFECT | Filing | Dec 15, 2021 | — |
| CERT | Filing | Dec 14, 2021 | — |
| CORRESP | Letter to the SEC | Dec 13, 2021 | — |
| CORRESP | Letter to the SEC | Dec 13, 2021 | — |
| 8-A12B | Filing | Dec 13, 2021 | — |
| SEC STAFF LETTER | Filing | Oct 19, 2021 | — |
| CORRESP | Letter to the SEC | Oct 15, 2021 | — |
| UPLOAD | Letter from the SEC | Oct 13, 2021 | — |
| SEC STAFF LETTER | Filing | Oct 13, 2021 | — |
| CORRESP | Letter to the SEC | Oct 6, 2021 | — |
| UPLOAD | Letter from the SEC | Sep 27, 2021 | — |
| CORRESP | Letter to the SEC | Sep 16, 2021 | — |
| UPLOAD | Letter from the SEC | Aug 16, 2021 | — |
| DRSLTR | Filing | Jul 20, 2021 | — |
| DRS | Filing | Jul 20, 2021 | — |
Showing 31 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- IMMX (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Los Angeles, CA
- SEC filer status
- , Emerging growth company
- SEC CIK
- 1873835
- Former names
- Immix Biopharma, Inc. (until Oct 27, 2026)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.